                         SEQUENCE LISTING

<110>  Araim Pharmaceuticals, Inc.
 
<120>  TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND
        TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE

<130>  12110-016-228

<140>  TBA
<141>  On even date herewith

<150>  61/847,455
<151>  2013-07-17

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide that have tissue protective activity

<400>  1

Arg Tyr Leu Leu Glu Ala Lys Glu Ala Glu Asn Ile Thr Thr Gly 
1               5                   10                  15  


<210>  2
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide that have tissue protective activity

<400>  2

Arg Tyr Leu Leu Glu Ala Lys Glu Ala Glu Asn Ile Thr Thr Gly Cys 
1               5                   10                  15      


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEG modified peptide that have tissue protective activity


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  PEG modified Gln residue

<400>  3

Xaa Glu Gln Leu Glu Arg Ala Leu Asn Ser Ser 
1               5                   10      


